LTR Pharma (ASX:LTP) Other Income (Minority Interest) : A$0.00 Mil (TTM As of Jun. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LTR Pharma Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. LTR Pharma's Other Income (Minority Interest) for the six months ended in Jun. 2023 was A$0.00 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma Other Income (Minority Interest) Historical Data

The historical data trend for LTR Pharma's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LTR Pharma Other Income (Minority Interest) Chart

LTR Pharma Annual Data

Trend

Jun21

Jun22

Jun23

Other Income (Minority Interest)

LTR Pharma Semi-Annual Data
	Jun21	Jun22	Jun23
Other Income (Minority Interest)	-	-	-

LTR Pharma Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Jun. 2023 was A$0.00 Mil.

LTR Pharma (ASX:LTP) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

LTR Pharma (ASX:LTP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LTR Pharma Ltd (ASX:LTP) » Definitions » Other Income (Minority Interest)

Comparable Companies

Traded in Other Exchanges

N/A

Address

9A/204 Alice Street, Brisbane, QLD, AUS, 4000

Website

https://www.ltrpharma.com

LTR Pharma Ltd is a clinical stage pharmaceutical company focused on holistically improving men's health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. SPONTAN is a Vardenafil-based nasal delivery formulation designed to be a lower dose fast-acting administration that provides a rapid and high availability to a patient's bloodstream compared with the incumbent oral ED treatment products on market.

LTR Pharma (ASX:LTP) Headlines

No Headlines